Showing results (151-160 of 346) with videos related to

Sort By:
Pageof 35
British Journal of Clinical Pharmacology|September 1, 1980
Repeated investigations of cyclophosphamide disposition in myeloma patients receiving intermittent chemotherapyG Edwards, R T Calvert, D Crowther, et al.
British Journal of Haematology|April 1, 1996
The effect of the GM-CSF/IL-3 fusion protein PIXY321 on bone marrow and circulating haemopoietic cells of previously untreated patients with cancerM Gheilmini, R Pettengell, L H Coutinho, et al.
The British Journal of Radiology|November 1, 1981
The role of abdominal computed tomography in lymphoma following treatmentG Blackledge, H Mamtora, D Crowther, et al.
British Journal of Cancer|July 1, 1981
Lack of prognostic value of the thymidine-labelling index in adult acute leukaemiaR L Sewell, T A Lister, S A Johnson, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
The disposition of cyclophosphamide in a group of myeloma patientsV Bramwell, R T Calvert, G Edwards, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1991
Workshop on growth factorsD Crowther, M B Sporn, A B Roberts, et al.
British Journal of Cancer|November 1, 1984
Response of differentiated but not anaplastic teratoma to interferonG J Rustin, S B Kaye, C J Williams, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1991
Weekly etoposide, methotrexate and actinomycin D, alternating with cyclophosphamide plus vincristine (EMA/CO): a phase II study in advanced gastric carcinomaP A Philip, G J Rustin, J A Ledermann, et al.
The International Journal of Biological Markers|January 1, 1989
Carcinoembryonic antigen levels in germ cell tumoursR N Hitchins, G J Rustin, H D Mitchell, et al.
British Journal of Cancer|October 1, 1975
Factors influencing prognosis in adults with acute myelogenous leukaemiaD Crowther, M E Beard, C J Bateman, et al.
Pageof 35